Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
538906
Reference Type
Journal Article
Title
Gender and autoimmunity
Author(s)
Zandman-Goddard, G; Peeva, E; Shoenfeld, Y
Year
2007
Is Peer Reviewed?
Yes
Journal
Autoimmunity Reviews
ISSN:
1568-9972
EISSN:
1873-0183
Volume
6
Issue
6
Page Numbers
366-372
Language
English
DOI
10.1016/j.autrev.2006.10.001
Abstract
The enhanced immunoreactivity in females is a double-edged sword that provides better protection against infections, but may lead to enhanced autoreactivity and thereby contribute to the induction of autoimmunity. Autoimmune diseases demonstrate a gender bias and represent the fifth leading cause of death by disease among females of reproductive age. Clinical and murine experimental studies indicate that the gender bias in autoimmunity may be influenced by sex hormones, predominantly displayed in the development and exacerbations of the prototypical autoimmune disease lupus. The associations between sex hormones and other autoimmune diseases are less clear. Our review on the impact of gender via sex hormones and sex related genes in the pathogenesis of several autoimmune diseases suggests that a better understanding of the underlying mechanisms behind the sexual dimorphism of the immune system may lead to the development of novel therapeutic approaches to autoimmunity. (C) 2006 Elsevier B.V. All rights reserved.
Keywords
gender; SLE; estrogen; prolactin; rheumatoid arthritis; systemic; sclerosis; systemic-lupus-erythematosus; myasthenia-gravis; klinefelters-syndrome; disease-activity; lpr/lpr mice; estrogen; scleroderma; prolactin; sclerosis; tamoxifen
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity